Clinical Trial Update: Phase 1 Safety Study of ALK-001 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 safety study of ALK-001 in healthy volunteers has completed, assessing safety in humans. It targets retinal degenerative conditions such as Stargardt di…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Stargardt Disease

Drugs mentioned

• ALK-001

Snippet

Sponsor: Alkeus Pharmaceuticals, Inc. | Conditions: Stargardt Disease, Age-related Macular Degeneration | Phase 1 | Status: COMPLETED